Cite
MLA Citation
T. Hughes et al.. “P704: ASCIMINIB PROVIDES DURABLE MOLECULAR RESPONSES IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) WITH THE T315I MUTATION: UPDATED EFFICACY AND SAFETY DATA FROM A PHASE I TRIAL.” HemaSphere, vol. 6, n.d., pp. 599–600. http://access.bl.uk/ark:/81055/vdc_100159756951.0x000011